ENLIVEX THERAP.LTD.IS-,01/ IL0011319527 /
| 26/04/2024 08:04:25 | Chg. -0.0500 | Volume | Bid21:53:09 | Ask21:53:09 | High | Low |
|---|---|---|---|---|---|---|
| 1.3300EUR | -3.62% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 1.3300 | 1.3300 |
GlobeNewswire
22/04
Enlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evalua...
GlobeNewswire
16/04
Enlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Cont...
GlobeNewswire
11/04
Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from...
GlobeNewswire
11/04
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsi...
GlobeNewswire
07/02
Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Metho...
GlobeNewswire
20/12/2023
Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients Wi...
GlobeNewswire
11/09/2023
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
GlobeNewswire
07/09/2023
Enlivex to Present at the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire
08/03/2022
Enlivex Announces Issuance of Israeli Patent Covering Allocetra Derived from Pooled Donor Cells
GlobeNewswire
22/02/2022
Enlivex Strengthens Management Team with the Appointment of Biotech Industry Veteran Einat Galamidi,...
GlobeNewswire
03/01/2022
Enlivex to Detail the Application of its Innovative Macrophage Reprogramming Cell Therapy to Unmet N...
GlobeNewswire
13/12/2021
Enlivex Receives Regulatory Authorization to Expand its Phase IIb Trial Evaluating Allocetra in Seve...
GlobeNewswire
07/12/2021
Enlivex Receives Regulatory Authorization to Expand its Phase II Sepsis Trial into Greece
GlobeNewswire
06/12/2021
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering the Treatment of Sepsis Pa...
GlobeNewswire
22/11/2021
Enlivex Announces Third Quarter 2021 Financial Results and Provides a Business Update
GlobeNewswire
10/11/2021
Spanish Regulator Grants Enlivex Authorization to Expand its Phase IIb Trial Evaluating Allocetra in...
GlobeNewswire
04/11/2021
Spanish Regulator Grants Enlivex Authorization To Expand Its Sepsis Phase II into Spain
GlobeNewswire
12/10/2021
Enlivex CSO Prof. Dror Mevorach Publishes Foundational Paper on the Pfizer–BioNTech COVID-19 Vaccin...
GlobeNewswire
05/10/2021
Enlivex Receives Notice of Allowance for Israeli Patent Application Covering Allocetra Derived from ...
GlobeNewswire
04/10/2021
Enlivex Announces the Peer-Reviewed Publication in Frontiers in Immunology of Clinical Data from Pha...
GlobeNewswire
22/09/2021
Enlivex Doses First Patient in Placebo-Controlled Phase IIb Clinical Trial Evaluating Allocetra in S...
GlobeNewswire
09/09/2021
Enlivex to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
GlobeNewswire
15/08/2021
Enlivex: After Review of Phase II Data, Israeli Ministry of Health Authorizes Initiation of a Multi-...
GlobeNewswire
09/08/2021
Enlivex Announces Second Quarter 2021 Financial Results and Provides a Business Update
